Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Total Debt (2024 - 2026)

Updated

Revium Rx (RVRC) recorded Total Debt of $1,000 in Q2 2026.

Analysis

Revium Rx (RVRC) Total Debt (2024 - 2026) Analysis & Trends

  • Across earlier years, Total Debt came in at $1,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Revium Rx 86.84 Mn 86.00 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Dec 31, 2025 1,000.00
Dec 31, 2024 1,000.00
API Access

Revium Rx Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RVRC&period=max&api_key=YOUR_API_KEY